Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023
- PMID: 36912521
- PMCID: PMC10132295
- DOI: 10.1097/JS9.0000000000000258
Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023
Conflict of interest statement
The authors declare no conflicts of interest, financial or otherwise.
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Figures
Comment in
-
A commentary on 'Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023'.Int J Surg. 2023 Oct 1;109(10):3197-3198. doi: 10.1097/JS9.0000000000000576. Int J Surg. 2023. PMID: 37851496 Free PMC article. No abstract available.
References
-
- YaleMedicine. Omicron and its Subvariants: A Guide to What We Know. By Kathy Katella, 3 February 2023. Accessed 26 January 2023. https://www.yalemedicine.org/news/5-things-to-know-omicron
-
- Iuliano AD, Brunkard JM, Boehmer TK, et al. . Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. MMWR Morb Mortal Wkly Rep 2022;71:146–152. - PMC - PubMed
-
- Mahase E. Covid-19: what do we know about XBB.1.5 and should we be worried? BMJ 2023;380:153. - PubMed
-
- World Health Organization, Information note on new COVID-19 Omicron subvariant XBB.1.5. https://www.emro.who.int/media/news/information-note-on-new-covid-19-omi...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous